Cipla partners with Eli Lilly to market diabetes drug Basaglar in India

in india •  7 years ago 

Moneycontrolcom
Drug firm Cipla today said it has partnered with Eli Lilly to market and distribute Lillys insulin glargine injection, Basaglar, in India.

Authors get paid when people like you upvote their post.
If you enjoyed what you read here, create your account today and start earning FREE STEEM!